Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Feb 19, 2016 · 10-K · 50 days after period end · 0001193125-16-469890
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Net Income | -$31.24M | -$20.62M | -$14.04M | -$7.74M |
| EPS Diluted | -$0.87 | -$0.71 | -$0.75 | -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Feb 19, 2016 · 50 d after period end
